Detecting ALK Rearrangement with RT-PCR: A Reliable Approach Compared with Next-Generation Sequencing in Patients with NSCLC

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1179-2000
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Detecting ALK Rearrangement with RT-PCR: A Reliable Approach Compared with Next-Generation Sequencing in Patients with NSCLC ; volume:25 ; number:4 ; day:16 ; month:6 ; year:2021 ; pages:487-494 ; date:7.2021
Molecular diagnosis & therapy ; 25, Heft 4 (16.6.2021), 487-494, 7.2021

Creator
Kuang, Yukun
Xu, Peihang
Wang, Jiyu
Zheng, Yifan
Sun, Xue
Li, Zimu
Gan, RunJing
Li, Huixia
Guo, Yubiao
Yao, Fei
Zhu, Changbin
Ke, Zunfu
Tang, Kejing
Contributor
SpringerLink (Online service)

DOI
10.1007/s40291-021-00532-8
URN
urn:nbn:de:101:1-2021101223235752846657
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Kuang, Yukun
  • Xu, Peihang
  • Wang, Jiyu
  • Zheng, Yifan
  • Sun, Xue
  • Li, Zimu
  • Gan, RunJing
  • Li, Huixia
  • Guo, Yubiao
  • Yao, Fei
  • Zhu, Changbin
  • Ke, Zunfu
  • Tang, Kejing
  • SpringerLink (Online service)

Other Objects (12)

ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients

ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients

Primary Resistance to ALK Inhibitors in a Patient with Nonsmall Cell Lung Cancer with ALK Rearrangement: A Case Report with Review of Literature

Primary Resistance to ALK Inhibitors in a Patient with Nonsmall Cell Lung Cancer with ALK Rearrangement: A Case Report with Review of Literature

Alecensa bei ALK-positivem NSCLC

Alecensa bei ALK-positivem NSCLC

Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement

Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement

Successful salvage surgery followed by second ALK–TKI after alectinib failure in a patient with ALK-positive NSCLC

Successful salvage surgery followed by second ALK–TKI after alectinib failure in a patient with ALK-positive NSCLC

Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC

Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC

P-glycoprotein confers acquired resistance to 17-DMAG in lung cancers with an ALK rearrangement

P-glycoprotein confers acquired resistance to 17-DMAG in lung cancers with an ALK rearrangement

Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC

Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC

Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis

Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

Predicting EGFR mutation, ALK rearrangement, and uncommon EGFR mutation in NSCLC patients by driverless artificial intelligence: a cohort study

Predicting EGFR mutation, ALK rearrangement, and uncommon EGFR mutation in NSCLC patients by driverless artificial intelligence: a cohort study

Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK

Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK

Related objects